TY - JOUR
T1 - Prosthesis Used in Microvascular Decompressions
T2 - A Multicenter Survey in Japan Focusing on Adverse Events
AU - Hasegawa, Mitsuhiro
AU - Hatayama, Toru
AU - Kondo, Akinori
AU - Nagahiro, Shinji
AU - Fujimaki, Takamitsu
AU - Amagasaki, Kenichi
AU - Arita, Kazunori
AU - Date, Isao
AU - Fujii, Yukihiko
AU - Goto, Takeo
AU - Hanaya, Ryosuke
AU - Higuchi, Yoshinori
AU - Hongo, Kazuhiro
AU - Inoue, Toru
AU - Kasuya, Hidetoshi
AU - Kayama, Takamasa
AU - Kawashima, Masatou
AU - Kohmura, Eiji
AU - Maehara, Taketoshi
AU - Matsushima, Toshio
AU - Mizobuchi, Yoshihumi
AU - Morita, Akio
AU - Nishizawa, Shigeru
AU - Noro, Shusaku
AU - Saito, Shinjiro
AU - Shimano, Hirofumi
AU - Shirane, Reizo
AU - Takeshima, Hideo
AU - Tanaka, Yuichiro
AU - Tanabe, Hidenori
AU - Toda, Hiroki
AU - Yamakami, Iwao
AU - Nishiyama, Yuya
AU - Ohba, Shigeo
AU - Hirose, Yuichi
AU - Suzuki, Takeya
N1 - Funding Information:
This study was proposed, discussed, and approved by the Japanese Society for MVD Surgery in its 17th annual meeting in 2015 and later refined by the society members in its 2016 meeting. We greatly appreciate for all the patients enrolled in this study. We also thank Mrs. Setsuko Hase for her work of the Secretariat. Contributors, Abe-H, Fukuoka University Hospital; Agari-T, Okayama University; Arimoto-H, Mishuku Hospital; Fukuda-M, Niigata University; Fukushima-K, Kasukabe Medical Center; Goto-H, Yamaguchi University Hospital; Goto-T, Shinshu University; Hadeishi-H, Kameda General Hospital; Hamasaki-S, Kumamoto University; Hara-T, Toranomon Hospital; Hiraishi-T, Brain Research Institute, Niigata University; Hirata-M, Osaka University Hospital; Hiroshima-S, Asahikawa Medical University; Hondo-H, Toyama Prefectural Hospital; Ikemura-G, Ajichi Neurosurgical Hospital; Inoue-T, Koto Memorial Hospital; Ishikawa-M, Jichi Medical University Saitama Medical Center; Iwai-K, Osaka City General Hospital; Izawa-H, Tokyto Medical University; Jitoh-J, Shiga University of Medical Science Hospital; Kagawa-m,Takamatsu Red Cross hospital; Katayama-K, Hirosaki University Hospital; Kawano-Y, Tokyo Medical and Dental University; Kimura-T, NTT Kanto Hospital; Kokubo-Y, Yamagata University Hospital; Kondo-T, Department of Rehabilitation, Tokyo University Hospital; Kumai-J, Shintokyo Hospital; Kurosaki-M, Tottori University Hospital; Masuoka-J, Saga University Hospital; Matsuda-M, Tsukuba university Hospital; Mikami-T, Sapporo Medical University; Miki-Y, Tesseikai Neurosurgical Hospital; Mochida-H, Asahi Central Hospital; Morimoto-M, Kochi medical center; Moriwaki-H, Hakodate Neurosurgical Hospital; Moroi-J, Akita Cerebrospinal and Cardiovascular Center; Morisako-T, Osaka City university; Nishimura-S, Southern Tohoku General Hospital; Nishizaki-T, Ube Kosan Central Hospital; Nitta-K, Hokuto Hospital; Nomura-K, Aoyama general Hospital; Obata-Y, Tokyo Medical and Dental University; Ohno-K, Yushima Clinic; Oka-Y, Nagoya city University; Okamura-T, Ube Kosan Central hospital; Onoda-K, Okayama Red Cross Hospital; Ota-S, Ota Memorial Hospital; Otani-N, National Defense Medical College; Owada-T, Iwate prefectural Isawa Hospital; Oya-S, Saitama Medical Center; Saitoh-A, Aomori Prefectural Hospital; Sakata-K, Kurume University Hospital; Sato-S, Southern Tohoku General Hospital; Seo-Y, Nakamura Memorial Hospital; Shima-H, Yokohama Sakae Kyosai Hospital; Shimamura-N, Hirosaki University; Shimokawa-N, Tsukazaki Hospital; Sumita-K, Tokyo Medical and Dental University; Suzuki-N, Aomori Rosai Hospital; Takabatake-Y, Fukui Saiseikai Hospital; Takada-A, Kumamoto Municipal Hospital; Takemae-N, Nagano Municipal hospital; Takemura-N, Aomori Municipal Hospital; Tani-S, Tokyo Women's Medical University Medical Center East; Tatsusawa-K, Kyoto Prefectural Hospital; Tsuruno-T, Yao Tokushukai Hospital; Umemura-T, University of Occupational and Environmental Health, Japan; Umeoka-K, Chiba Hokuso Hospital, Nippon Medical University; Yamada-Y, FHU Bantane Hospital; Yamagami-M, Ajichi Neurosurgical Hospital; Yamamoto-T, Tsukuba University Hospital; Yamazaki-T, Mito Medical Center; Yasuda-S, Shiroyama Hospital.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/10
Y1 - 2019/10
N2 - Objective: To investigate the characteristics of materials used as prostheses for microvascular decompression surgery (MVDs) in Japan and their possible adverse events (AEs) to determine preferable materials for MVDs. Methods: A questionnaire was sent to all members of the Japanese Society for MVDs, and answers were obtained from 59 institutions. Results: Among a total of 2789 MVDs, 1088 operations for trigeminal neuralgia, 1670 for hemifacial spasm, and 31 others, including 117 reoperations, were performed between April 2011 and March 2014. Nonabsorbable material was used in 96.5% of MVDs, including polytetrafluoroethylene (PTFE) (80.5%), polyurethane (11.9%), expanded PTFE (2.1%), and silk thread (1.47%). The use of absorbable materials, including fibrin glue (87.5%), cellulose (13.5%), gelatin (4,77%), and collagen (1.76%), was reported. The major combinations were PTFE with fibrin glue (58.7%) followed by PTFE alone (7.60%). Eighty-eight AEs in 85 (3.2%) cases were reported among 2672 first operations. AEs included 51 central nervous system dysfunctions, 15 wound infections/dehiscence, and 10 others, which were presumed to be related to the intraoperative procedure. Among relatively high-, moderate-, and low-volume centers, there were no significant differences in the frequency of AEs (P = 0.077). Tissue-prosthesis adhesion and/or granuloma formation were reported in 13 cases of 117 reoperations. The incidence of adhesion-related recurrence was 11.1% of all reoperations. Conclusions: The number of AEs was quite low in this survey, and intradural use of any prosthesis reported in this paper might be justified; however, further development of easily handled and less-adhesive prosthesis materials is awaited.
AB - Objective: To investigate the characteristics of materials used as prostheses for microvascular decompression surgery (MVDs) in Japan and their possible adverse events (AEs) to determine preferable materials for MVDs. Methods: A questionnaire was sent to all members of the Japanese Society for MVDs, and answers were obtained from 59 institutions. Results: Among a total of 2789 MVDs, 1088 operations for trigeminal neuralgia, 1670 for hemifacial spasm, and 31 others, including 117 reoperations, were performed between April 2011 and March 2014. Nonabsorbable material was used in 96.5% of MVDs, including polytetrafluoroethylene (PTFE) (80.5%), polyurethane (11.9%), expanded PTFE (2.1%), and silk thread (1.47%). The use of absorbable materials, including fibrin glue (87.5%), cellulose (13.5%), gelatin (4,77%), and collagen (1.76%), was reported. The major combinations were PTFE with fibrin glue (58.7%) followed by PTFE alone (7.60%). Eighty-eight AEs in 85 (3.2%) cases were reported among 2672 first operations. AEs included 51 central nervous system dysfunctions, 15 wound infections/dehiscence, and 10 others, which were presumed to be related to the intraoperative procedure. Among relatively high-, moderate-, and low-volume centers, there were no significant differences in the frequency of AEs (P = 0.077). Tissue-prosthesis adhesion and/or granuloma formation were reported in 13 cases of 117 reoperations. The incidence of adhesion-related recurrence was 11.1% of all reoperations. Conclusions: The number of AEs was quite low in this survey, and intradural use of any prosthesis reported in this paper might be justified; however, further development of easily handled and less-adhesive prosthesis materials is awaited.
UR - http://www.scopus.com/inward/record.url?scp=85068903488&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068903488&partnerID=8YFLogxK
U2 - 10.1016/j.wneu.2019.06.053
DO - 10.1016/j.wneu.2019.06.053
M3 - Article
C2 - 31207376
AN - SCOPUS:85068903488
SN - 1878-8750
VL - 130
SP - e251-e258
JO - World Neurosurgery
JF - World Neurosurgery
ER -